Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.
No Thumbnail Available
All Authors
Claudiani, S.
Chee, L.
Fernando, F.
Brown, L.
Achandira, UM.
Khan, A.
Rothwell, K.
Hayden, C.
Koutsavlis, I.
Hannah, G.
LTHT Author
Rothwell, Kate
LTHT Department
Haematology
Non Medic
Publication Date
2024
Item Type
Letter
Research Support, Non-U.S. Gov't
Research Support, Non-U.S. Gov't
Language
Subject
Subject Headings
Abstract
Probability of treatment-free remission (TFR) in CML patients with additional chromosomal abnormalities (ACA) in the Philadelphia-positive clone or variant Philadelphia translocations (ACA/Var-Ph group, blue panel), in those with no cytogenetic abnormality other than the classical Philadelphia translocation (c-Ph group, green panel) and in the subgroups of CML patients with high-risk ACA (HR-ACA, yellow panel) and Var-Ph (red panel).
Journal
American Journal of Hematology